About Dr Mark Larance

Dr Mark Larance's research group uses mass spectrometry-based proteomics to characterise the response to intermittent fasting in both mice and humans. We are interested in determining the molecular mechanisms that govern the response and the beneficial phenotypes it can induce.

In animals, short periods of nutrient deprivation, such as intermittent fasting, have been shown to provide benefits with regard to cancer risk and ageing. Dr Larance's reasearch laboratry aims are to identify how this is occurring at the protein-level, determine how intermittent fasting can improve metabolic health and improve the nutrient deprivation regimes for implementation in humans, for the prevention and treatment of cancer. To achieve this, his laboratory use state-of-the-art quantitative proteomics to give an unprecedented insight into protein identity, abundance, and interactions.

Dr Mark Larance is a CINSW Future Research Leader Fellow in the School of Life and Environmental Sciences, and is also a member of the Charles Perkins Centre.

For ore information about Dr Mark Larance, refer to his Academic Profile Online.